Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2008. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2689573016 | Parenteral form dolasetron (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2693672011 | Parenteral form dolasetron | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3487393011 | Product containing dolasetron in parenteral dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3495765011 | Product containing dolasetron in parenteral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3495766012 | Dolasetron in parenteral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3709669012 | Dolasetron-containing product in parenteral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3709670013 | Product containing dolasetron in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing dolasetron in parenteral dose form (medicinal product form) | Is a | Product containing dolasetron | true | Inferred relationship | Existential restriction modifier | ||
| Product containing dolasetron in parenteral dose form (medicinal product form) | Has active ingredient | Dolasetron | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing dolasetron in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing dolasetron in parenteral dose form (medicinal product form) | Is a | Product manufactured as parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing dolasetron in parenteral dose form (medicinal product form) | Plays role | Antiemetic therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dolasetron mesilate 20mg/mL injection solution 0.625mL vial | Is a | False | Product containing dolasetron in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Dolasetron mesilate 20mg/mL injection solution 5mL vial | Is a | False | Product containing dolasetron in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Is a | False | Product containing dolasetron in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing only dolasetron in parenteral dose form (medicinal product form) | Is a | True | Product containing dolasetron in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR